{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:01:09Z","timestamp":1792058469243,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cell.2020.04.042","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T04:15:41Z","timestamp":1588565741000},"page":"969-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":430,"title":["Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection"],"prefix":"10.1016","volume":"181","author":[{"given":"Mihai G.","family":"Netea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Dom\u00ednguez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinout","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2020.04.042_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2020.04.042_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2020.04.042_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cell.2020.04.042_bib4","article-title":"Connecting BCG Vaccination and COVID-19: Additional Data","author":"Dayal","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cell.2020.04.042_bib5","first-page":"173","article-title":"Increased resistance to virus infections of mice inoculated with BCG (Bacillus calmette-gu\u00e9rin)","volume":"127","author":"Floc\u2019h","year":"1976","journal-title":"Ann. Immunol. (Paris)"},{"key":"10.1016\/j.cell.2020.04.042_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/trstmh\/tru197","article-title":"BCG-associated heterologous immunity, a historical perspective: intervention studies in animal models of infectious diseases","volume":"109","author":"Freyne","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cell.2020.04.042_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2020.04.042_bib8","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.04.042_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2020.04.042_bib10","article-title":"COVID-19: A model correlating BCG vaccination to protection from mortality implicates trained immunity","author":"Green","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cell.2020.04.042_bib11","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/j.vaccine.2014.04.084","article-title":"Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults","volume":"32","author":"Hatherill","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2020.04.042_bib12","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cell.2020.04.042_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-\u03b3-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.cell.2020.04.042_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2020.04.042_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0264-410X(87)90155-1","article-title":"Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice","volume":"5","author":"Ishihara","year":"1987","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2020.04.042_bib16","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2020.04.042_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.04.042_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.12.007","article-title":"Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol\u00ae (Poly IC:LC), in a lethal SARS-CoV-infected BALB\/c mouse model","volume":"139","author":"Kumaki","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2020.04.042_bib19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ni.3857","article-title":"A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes","volume":"18","author":"Machiels","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2020.04.042_bib20","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","author":"Miller","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cell.2020.04.042_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.04.042_bib21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cell.2020.04.042_bib22","doi-asserted-by":"crossref","first-page":"e0180143","DOI":"10.1371\/journal.pone.0180143","article-title":"Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2020.04.042_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. Tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2020.04.042_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2020.04.042_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille Calmette-Gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2020.04.042_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"[Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations]","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nippon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.cell.2020.04.042_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.03.021","article-title":"A dynamic immune response shapes COVID-19 progression","author":"Ong","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2020.04.042_bib28","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2020.04.042_bib29","doi-asserted-by":"crossref","first-page":"e1000240","DOI":"10.1371\/journal.ppat.1000240","article-title":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV","volume":"4","author":"Sheahan","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2020.04.042_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cell.2020.04.042_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.04.042_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/infdis\/136.2.171","article-title":"Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Gu\u00e9rin","volume":"136","author":"Spencer","year":"1977","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2020.04.042_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3181\/00379727-152-39327","article-title":"Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection","volume":"152","author":"Starr","year":"1976","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.cell.2020.04.042_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/iai.20.1.312-314.1978","article-title":"Effect of Mycobacterium tuberculosis BCG infection on the resistance of mice to ectromelia virus infection: participation of interferon in enhanced resistance","volume":"20","author":"Suenaga","year":"1978","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cell.2020.04.042_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","article-title":"Host and Environmental Factors Influencing Individual Human Cytokine Responses","volume":"167","author":"Ter Horst","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.04.042_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.04.042_bib37","doi-asserted-by":"crossref","first-page":"e00638","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.cell.2020.04.042_bib38","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.cell.2020.04.042_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cell.2020.04.042_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","author":"Wu","year":"2020","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cell.2020.04.042_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cell.2020.04.042_bib42","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","article-title":"Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity","volume":"175","author":"Yao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.04.042_bib43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420305079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420305079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:45:03Z","timestamp":1758800703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867420305079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0092867420305079"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2020.04.042","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2020.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}